ArticleFrontiers in oncology2024

DSP-0509, a TLR7 agonist, exerted synergistic anti-tumor immunity combined with various immune therapies through modulating diverse immune cells in cancer microenvironment.

Yosuke Ota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.